References

  1. Vázquez García J, Almagro Sánchez M, Fonseca Capdevila E. Multiple neutrophilic dermatoses in myelodysplastic syndrome . Clinical and Experimental Dermatology. 2001; 26(5): 398-401. PubMed | Google Scholar

  2. Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and sweet's syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol. 2013; 45(2):202-10. PubMed | Google Scholar

  3. Lear JT, Atherton MT, Byrne JPH. Neutrophilic dermatoses: pyoderma gangrenosum and sweet's syndrome. Postgrad Med J.1997; 73(856):65-8. PubMed | Google Scholar

  4. Ahmad K, Ramsay B. Pyoderma gangrenosum associated with subcorneal pustular dermatosis and IgA myeloma. Clin Exp Dermatol. 2009;34(1):46-8. PubMed | Google Scholar

  5. Brahimi N, Maubec E, Palazzo E, Larger E, Mohammedi K, Landry J et al. Pyoderma gangrenosum with aseptic spleen abscess. Ann Dermatol Venereol. 2009;136 (1):46-9. PubMed | Google Scholar

  6. Malone JC, Slone SP, Wills-Frank LA, Fearneyhough PK , Lear SC , Goldsmith U et al. Vascular inflammation (vasculitis) in Sweet syndrome. Arch Dermatol. 2002;138 (3): 345-9. PubMed | Google Scholar

  7. Shankar S, Sterling JC, Rytina E. Pustular pyoderma gangrenosum. Clin Exp Dermatol. 2003; 28 (6):600-3. PubMed | Google Scholar

  8. Javaid B. Pyoderma gangrenosum in Crohn's disease, unusual presentation and management. Case Rep Gastroenterol. 2009; 3(3):50-3. PubMed | Google Scholar

  9. Fonder MA et al. Adalimumab therapy for recalcitrant pyoderma gangrenosum. J Burns Wounds. 2006; 20;5:e8. PubMed | Google Scholar

  10. Juillerat P, Christen-Zäch S, Troillet FX, Gallot-Lavallée S, Pannizzon RG, Michetti P. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis: case report and literature review. Dermatology. 2007;215(3):245-51. PubMed | Google Scholar